Tumor-associated macrophages as a prognostic parameter in multiple myeloma
Authors:
- 20 January 2013
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 92 (5) , 669-677
Abstract
The interaction between multiple myeloma (MM) cells and the bone marrow stroma constitutes the basis of myeloma pathogenesis and has led the way for the corresponding therapeutic strategies. The aim of this study is to evaluate tumor-associated macrophages (TAMs) which is an important element of bone marrow stroma and its prognostic relevance in newly diagnosed MM patients. We also wanted to determine the association between TAMs and microvessel density (MVD). Sixty-eight patients, who were diagnosed with MM at the Department of Hematology, Gazi University Hospital, between January 2000 and January 2011, were reviewed retrospectively. Tumor-associated macrophages were evaluated by staining with anti-CD68 and anti-CD163 monoclonal antibodies, and MVD was evaluated by factor VIII staining. Median age was 60 (range, 40–84) years with 36 males and 32 females. The number of both CD 68+ and CD 163+ cells had a negative impact on OS at 6 years (p = 0.013 vs. 0.036; p = 0.015 vs. 0.039) in univariate and multivariate analysis in which age, sex, ISS, the induction treatment, and response to induction treatment are included as variables. High-grade MVD was found to be associated with increased CD163+ cell count. In conclusion, TAMs seems to be a promising prognostic histopathological marker in newly diagnosed MM patients.Keywords
This publication has 41 references indexed in Scilit:
- New Insights into Therapeutic Targets in MyelomaHematology-American Society Hematology Education Program, 2011
- B cells and macrophages in cancer: yin and yangNature Medicine, 2011
- Macrophages, innate immunity and cancer: balance, tolerance, and diversityCurrent Opinion in Immunology, 2010
- Bone marrow microenvironment and the identification of new targets for myeloma therapyLeukemia, 2008
- The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophagesCritical Reviews in Oncology/Hematology, 2008
- Multiple myeloma: A prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironmentJournal of Cellular Biochemistry, 2007
- Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactionsExperimental Hematology, 2007
- The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: Interplay of growth factors, their receptors and stromal interactionsEuropean Journal of Cancer, 2006
- Angiogenesis in multiple myelomaEuropean Journal of Cancer, 2006
- Bone marrow angiogenesis in multiple myelomaLeukemia, 2005